Molecular Targets of Cannabidiol in Neurological Disorders

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neurotherapeutics

• Publication date

  2015-08-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13311-015-0377-3PMID 26264914PMCID PMC4604182
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diversity of susceptible hosts in canine distemper virus infection: a systematic review and data synthesis

  2016cited by this paper
• The analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor.

  2015cited by this paper
• Ageing and inflammation - A central role for mitochondria in brain health and disease.

  2015cited by this paper
• Central administration of GPR55 receptor agonist and antagonist modulates anxiety‐related behaviors in rats

  2015cited by this paper
• Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance.

  2015cited by this paper
• The Effect of Cannabidiol on Ischemia/Reperfusion-Induced Ventricular Arrhythmias

  2015cited by this paper
• Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis

  2015cited by this paper
• Protective Effects of Melatonin and Mitochondria-targeted Antioxidants Against Oxidative Stress: A Review.

  2015cited by this paper
• Suppression of Peripheral Pain by Blockade of Voltage‐Gated Calcium 2.2 Channels in Nociceptors Induces RANKL and Impairs Recovery From Inflammatory Arthritis in a Mouse Model

  2015cited by this paper
• AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia

  2015cited by this paper
• Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice

  2015cited by this paper
• Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

  2015influential reference
• Neuroinflammation in Alzheimer's disease.

  2015cited by this paper
• Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration

  2015cited by this paper
• Melatonin Modulates the Immune System Response and Inflammation in Diabetic Rats Experimentally-Induced by Alloxan

  2015cited by this paper
• Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy.

  2015cited by this paper
• Differential Expression of Cytochrome P450 Enzymes from the CYP2C Subfamily in the Human Brain

  2015cited by this paper
• Cannabinoid-Induced Changes in the Activity of Electron Transport Chain Complexes of Brain Mitochondria

  2015cited by this paper
• Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy

  2015cited by this paper
• Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.

  2015cited by this paper
• Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm.

  2015cited by this paper
• The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy

  2015cited by this paper
• Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)*

  2015cited by this paper
• Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities

  2015cited by this paper
• Nicotinic acetylcholine receptor α7 subunit is involved in the cobratoxin-induced antinociception in an animal model of neuropathic pain.

  2015cited by this paper
• Epilepsy But Not Mobile Phone Frequency (900 MHz) Induces Apoptosis and Calcium Entry in Hippocampus of Epileptic Rat: Involvement of TRPV1 Channels

  2014cited by this paper
• FABP3 Protein Promotes α-Synuclein Oligomerization Associated with 1-Methyl-1,2,3,6-tetrahydropiridine-induced Neurotoxicity*

  2014cited by this paper
• Modulation of adenosinergic system and its application for the treatment of epilepsy

  2014cited by this paper
• Handbook of Cannabis

  2014cited by this paper
• T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants

  2014cited by this paper
• Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.

  2014cited by this paper
• Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease.

  2014cited by this paper
• Electromagnetic radiation (Wi-Fi) and epilepsy induce calcium entry and apoptosis through activation of TRPV1 channel in hippocampus and dorsal root ganglion of rats

  2014cited by this paper
• Involvement of central TRPV1 receptors in pentylenetetrazole and amygdala-induced kindling in male rats

  2014cited by this paper
• Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation.

  2014cited by this paper
• A double‐blind, randomized, placebo‐controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment

  2014cited by this paper
• Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.

  2014cited by this paper
• Drug treatment of epilepsy in adults

  2014cited by this paper
• Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice

  2014cited by this paper
• Norisoboldine attenuates inflammatory pain via the adenosine A1 receptor

  2014cited by this paper
• Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington's disease.

  2014cited by this paper
• Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

  2014cited by this paper
• Mitochondrial Dysfunctions in Neurodegenerative Diseases: Relevance to Alzheimer's Disease

  2014cited by this paper
• Genetic background of febrile seizures

  2014cited by this paper
• The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type‐2

  2014cited by this paper
• “Is dopamine involved in Alzheimer's disease?”

  2014cited by this paper
• Role of PPARγ in the Differentiation and Function of Neurons

  2014cited by this paper
• Auricular Electroacupuncture Reduced Inflammation-Related Epilepsy Accompanied by Altered TRPA1, pPKCα, pPKCε, and pERk1/2 Signaling Pathways in Kainic Acid-Treated Rats

  2014cited by this paper
• Cannabidiol inhibits paclitaxel‐induced neuropathic pain through 5‐HT1A receptors without diminishing nervous system function or chemotherapy efficacy

  2014cited by this paper
• Transient Receptor Potential Ion Channels: Powerful Regulators of Cell Function

  2014cited by this paper
• Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.

  2014cited by this paper
• Targeting the α7 nicotinic acetylcholine receptor to prevent progressive dementia and improve cognition in adults with Down's syndrome.

  2014cited by this paper
• Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice

  2014cited by this paper
• Blocking TRPV1 in Nucleus Accumbens Inhibits Persistent Morphine Conditioned Place Preference Expression in Rats

  2014cited by this paper
• Cannabidiol Improves Vasorelaxation in Zucker Diabetic Fatty Rats through Cyclooxygenase Activation

  2014cited by this paper
• Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability.

  2014influential reference
• Mitohormesis: Promoting Health and Lifespan by Increased Levels of Reactive Oxygen Species (ROS)

  2014cited by this paper
• Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease

  2014cited by this paper
• Cannabinoid-induced changes in respiration of brain mitochondria.

  2014cited by this paper
• Diphenyl Ditelluride Induces Anxiogenic-Like Behavior in Rats by Reducing Glutamate Uptake

  2014cited by this paper
• Influence of Cytochrome P450, Family 2, Subfamily D, Polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics.

  2014cited by this paper
• Role of TRPV1 in susceptibility to PTZ-induced seizure following repeated hyperthermia challenges in neonatal mice.

  2014cited by this paper
• Stimulation of the α7 Nicotinic Acetylcholine Receptor Protects against Neuroinflammation after Tibia Fracture and Endotoxemia in Mice

  2014cited by this paper
• The control of brain mitochondrial energization by cytosolic calcium: The mitochondrial gas pedal

  2013cited by this paper
• Opiates modulate thermosensation by internalizing cold receptor TRPM8.

  2013cited by this paper
• The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis.

  2013cited by this paper
• CB1 receptor signaling regulates social anxiety and memory

  2013cited by this paper
• Glycine receptors and brain development

  2013cited by this paper
• The Endocannabinoid System: A Putative Role in Neurodegenerative Diseases

  2013cited by this paper
• Piperine exerts anti-seizure effects via the TRPV1 receptor in mice.

  2013cited by this paper
• Role of Redox Signaling in Neuroinflammation and Neurodegenerative Diseases

  2013cited by this paper
• The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation.

  2013cited by this paper
• Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain.

  2013cited by this paper
• Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses

  2013cited by this paper
• Adenosine: setting the stage for plasticity.

  2013cited by this paper
• A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice

  2013influential reference
• Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?

  2013cited by this paper
• Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19.

  2013cited by this paper
• Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.

  2013cited by this paper
• Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells

  2013influential reference
• Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors.

  2013cited by this paper
• Endocannabinoids blunt the augmentation of synaptic transmission by serotonin 2A receptors in the nucleus tractus solitarii (nTS).

  2013cited by this paper
• Reduced VDAC1 Protects Against Alzheimer's Disease, Mitochondria, and Synaptic Deficiencies

  2013cited by this paper
• Effects of cannabinoids and endocannabinoid hydrolysis inhibition on pentylenetetrazole-induced seizure and electroencephalographic activity in rats.

  2013cited by this paper
• Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death

  2013influential reference
• TRPV1 antagonist capsazepine suppresses 4-AP-induced epileptiform activity in vitro and electrographic seizures in vivo.

  2013cited by this paper
• Structural requirements for potent direct inhibition of human cytochrome P450 1A1 by cannabidiol: role of pentylresorcinol moiety.

  2013cited by this paper
• Spinal actions of ω‐conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model

  2013cited by this paper
• Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings.

  2013cited by this paper
• Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors.

  2013cited by this paper
• Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure

  2013cited by this paper
• Research advances in basic mechanisms of seizures and antiepileptic drug action

  2013cited by this paper
• Evaluation of serotonin 5‐HT1A receptors in rodent models using [18F]mefway PET

  2013cited by this paper
• Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents.

  2013cited by this paper
• Functional role of alpha7 nicotinic receptor in chronic neuropathic and inflammatory pain: studies in transgenic mice.

  2013cited by this paper
• Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.

  2013cited by this paper
• Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.

  2013influential reference
• Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT₁A receptor.

  2013cited by this paper
• Endocannabinoid signalling in Alzheimer's disease.

  2013cited by this paper
• Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

  2013cited by this paper

• Effect of cannabidiol on traumatic brain injury related neuronal damage pathways

  2026cites this paper
• Long-term cannabidiol treatment did not restore bone microstructural defects in skeletally mature ovariectomized Sprague-Dawley rats

  2026cites this paper
• TRPV2 regulates cell fate in the human granulosa-like tumor cell line KGN: implications for granulosa cell tumors and cannabidiol

  2026cites this paper
• Cannabidiol suppresses emergency MDSCs generation by disturbing EEF1B2-mediated C/EBPβ protein synthesis in colorectal adenomas

  2026cites this paper
• Cannabidiol–Ion Channel Interactions Represent a Promising Preventive and Therapeutic Strategy in Hepatocellular Carcinoma

  2026cites this paper
• Simultaneous quantitative analysis of epimeric and Δ 8 /Δ 9 positional isomers of synthetic THC analogs and natural cannabinoids in formulated products by UHPLC-DAD with optional ESI/TOFMS confirmation

  2026cites this paper
• Unifying Phytochemistry, Analytics, and Target Prediction to Advance Dendropanax morbifera Bioactive Discovery

  2026cites this paper
• Beyond the High: Therapeutic Insights into Cannabis Sativa and Endocannabinoid Control of Pain

  2026cites this paper
• Ameliorating Seizures in Dravet Syndrome: A Review of Newly Approved and Investigational Drugs, RNA and Gene-Based Therapies.

  2026cites this paper
• Cannabidiol modulates brain molecular alterations, gut microbiota dysbiosis and alcohol self-administration in a mouse model of fetal alcohol spectrum disorder.

  2025cites this paper
• Assessing the Neuroprotective Benefits of Cannabis Sativa in Epilepsy Management

  2025cites this paper
• Efficacy and safety of cannabidiol in children with developmental and epileptic encephalopathies: A systematic review.

  2025cites this paper
• Innovative Strategies to Enhance the Bioavailability of Cannabidiol: Nanotechnology and Advanced Delivery Systems

  2025cites this paper
• Full-spectrum cannabis extracts for women with chronic pain syndromes: a real-life retrospective report of multi-symptomatic benefits after treatment with individually tailored dosage schemes

  2025cites this paper
• Generation of Neural Stem/Progenitor-like Cells from Cultured Human Peripheral Blood Mononuclear Cells combined with Cannabidiol

  2025cites this paper
• Molecular targets of cannabinoids and their derivatives in epilepsy – a review with focus on CBD

  2025cites this paper
• Cannabidiol dampens propagation of hippocampal hyperactivity and differentially modulates feedforward and feedback inhibition

  2025cites this paper
• The Impact of Major and Minor Phytocannabinoids on the Maintenance and Function of INS-1 β-Cells Under High-Glucose and High-Lipid Conditions

  2025cites this paper
• Efficacy and safety of pharmacological and non-pharmacological therapies in Lennox-Gastaut syndrome: a systematic review and network meta-analysis

  2025cites this paper
• Chemical diversity, receptor binding affinity, and pharmacology of phytocannabinoids: Insights into neuronal mechanisms.

  2025cites this paper
• Cannabidiol mitigates alcohol dependence and withdrawal with neuroprotective effects in the basolateral amygdala and striatum

  2025cites this paper
• [Low Abuse Potential of Plant-Derived Highly Purified Cannabidiol: A Narrative Review].

  2025cites this paper
• Therapeutic potential of cannabidiol in oral disorders: A systematic review of clinical evidence.

  2025cites this paper
• Cannabis: What We Use, Why It Matters, and When It Is Prescribed (Ethics, Policy, and Practice)

  2025cites this paper
• Development, characterization and in vitro assessment of a novel self-microemulsifying drug delivery system to increase cannabidiol intestinal bioaccessibility.

  2025cites this paper
• Development and Blood–Brain Barrier Penetration of Nanovesicles Loaded with Cannabidiol

  2025cites this paper
• Dose- and tissue-dependent effects of cannabidiol on antioxidant status in developing chicken embryos

  2025cites this paper
• The phytocannabinoid cannabidivarin alleviates cognitive and social behaviour deficits in the sub-chronic phencyclidine rat model of relevance for schizophrenia.

  2025cites this paper
• Cannabidiol potentiates phenobarbital effects in the control of pentylenetetrazole (PTZ)-induced epileptic seizures in neonate rats

  2025cites this paper
• Metadynamics simulations and site‐directed mutagenesis determine the binding of cannabidiol to the adenosine A2A receptor

  2025cites this paper
• Cannabinoids: Adaptogens or Not?

  2025cites this paper
• Cannabis Oil Protects Against Valproic Acid–Induced Autism Spectrum Disorder by Reducing Oxidative Stress

  2025cites this paper
• Beyond the hype - who uses cannabidiol for self-medication – and why: a cross-sectional study in Germany

  2025influential citation
• Full Spectrum Cannabis Oil for the treatment of chronic pain and sleep dysfunction in myofascial temporomandibular disorder: a case report.

  2025cites this paper
• Effects of cannabidiol (CBD) treatment on age-related cognitive decline in C57 mice

  2025cites this paper
• Cannabidiol in Foods and Food Supplements: Evaluation of Health Risks and Health Claims

  2025cites this paper
• A High-Dose THC Cannabis Oil Improves Motor and Non-motor Symptoms in Parkinson’s Disease: A Case Report

  2025cites this paper
• Electrophysiology in neuropathic pain: a bibliometric analysis and literature review

  2025cites this paper
• Prediction and assessment of energetically-favored binding orientation of cannabidiol at hNav1.1 channel using all-atom molecular dynamics simulations.

  2025cites this paper
• Comparison between Cannabidiol and Fluoxetine effects on chronic neuropathic pain and depression comorbid in rats

  2025cites this paper
• Effect of Fatty Acyl Composition for Lysophosphatidylinositol on Neuroinflammatory Responses in Primary Neuronal Cultures

  2025cites this paper
• THC, CBD and minor cannabinoid CBDV differently modulate hippocampal neurons firing.

  2025cites this paper
• Affinity‐Based Protein Profiling Reveals IDH2 as a Mitochondrial Target of Cannabinol in Receptor‐Independent Neuroprotection

  2025cites this paper
• The effect of cannabidiol on neurometabolite levels in alcohol use disorder.

  2025cites this paper
• Cannabidiol reduces synaptic strength and neuronal firing in layer V pyramidal neurons of the human cortex with drug-resistant epilepsy

  2025cites this paper
• Acute cannabidiol (CBD), tetrahydrocannabinol (THC) and their mixture (THC:CBD) exert differential effects on brain activity and blood flow in rats: A translational neuroimaging study.

  2025cites this paper
• Utilization of Cannabidiol in Post-Organ-Transplant Care

  2025cites this paper
• Cannabidiol interactions with oxycodone analgesia in an operant orofacial cutaneous thermal pain assay following oral administration in rats.

  2025cites this paper
• Cannabidiol improves L-DOPA-induced dyskinesia and modulates neuroinflammation and the endocannabinoid, endovanilloid and nitrergic systems.

  2025cites this paper
• Potential causal link between antiseizure medication targets and cognitive function: A mendelian randomization study.

  2025cites this paper
• Autism Spectrum Disorder and Use of Medical Cannabis

  2025cites this paper
• Efficacy and Safety of Topical 5% Cannabidiol Plus Myrcene for the Treatment of Vestibulodynia: A Multi-Centric Randomized Controlled Trial

  2025cites this paper
• Cannabidiol attenuates lipid metabolism and induces CB1 receptor-mediated ER stress associated apoptosis in ovarian cancer cells

  2025cites this paper
• Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery

  2025cites this paper
• Ion channels and G protein-coupled receptors: Cannabidiol actions on disorders of excitability and synaptic excitatory-inhibitory ratio.

  2025cites this paper
• Balancing efficacy and safety: The dual impact of antiseizure medications on the developing brain.

  2025cites this paper
• Cannabidiol for Orofacial and Upper-Quarter Pain: A Systematic Evaluation of Therapeutic Potential

  2025cites this paper
• Exploring the Potential of Nonpsychoactive Cannabinoids in the Development of Materials for Biomedical and Sports Applications.

  2024cites this paper
• The role of the endocannabinoid system in the pathogenesis and treatment of epilepsy

  2024cites this paper
• A cautionary tale of paradox and false positives in cannabidiol research

  2024cites this paper
• Maternal ingestion of cannabidiol (CBD) in mice leads to sex-dependent changes in memory, anxiety, and metabolism in the adult offspring, and causes a decrease in survival to weaning age.

  2024cites this paper
• CBD’s potential impact on Parkinson’s disease: An updated overview

  2024cites this paper
• Cannabinoid for alcohol use disorder.

  2024cites this paper
• Cannabidiol partially rescues behavioral, neuroinflammatory and endocannabinoid dysfunctions stemming from maternal obesity in the adult offspring.

  2024cites this paper
• A novel insight into the antidepressant effect of cannabidiol: possible involvement of the 5-HT1A, CB1, GPR55, and PPARγ receptors

  2024cites this paper
• Effects of Cannabidiol (CBD) on Doxorubicin-Induced Anxiety and Depression-like Behaviors and mRNA Expression of Inflammatory Markers in Rats

  2024cites this paper
• Principais alvos farmacológicos e potencial terapêutico do canabidiol (CDB)

  2024cites this paper
• An overview of major depression disorder: The endocannabinoid system as a potential target for therapy

  2024cites this paper
• Cannabidiol modulation of immune cell function: in vitro insights and therapeutic implications for atopic dermatitis

  2024cites this paper
• Evaluation of The Therapeutic Use of Cannabidiol in Children With Congenital Zika Virus Syndrome

  2024influential citation
• Cannabis for medicine and food: A benefit vs risk critical appraisal

  2024cites this paper
• The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial

  2024cites this paper
• GABRG2 mutations in genetic epilepsy with febrile seizures plus: structure, roles, and molecular genetics

  2024cites this paper
• Cannabidiol enhances socially transmitted food preference: a role of acetylcholine in the mouse basal forebrain

  2024cites this paper
• Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study

  2024cites this paper
• Exploring the efficacy and safety of cannabidiol in individuals with epilepsy: an umbrella review of meta-analyses and systematic reviews

  2024cites this paper
• Plant-derived compounds and neurodegenerative diseases: Different mechanisms of action with therapeutic potential.

  2024cites this paper
• Exploring the safety of cannabidiol (CBD): A comprehensive in vitro evaluation of the genotoxic and mutagenic potential of a CBD isolate and extract from Cannabis sativa L.

  2024cites this paper
• Unraveling the Mechanisms of Cannabidiol’s Pharmacological Actions: A Comprehensive Research Overview

  2024cites this paper
• Comparison of various doses of oral cannabidiol for treating refractory epilepsy indications: a network meta-analysis

  2024cites this paper
• Cannabidiol and Neurodegeneration: From Molecular Mechanisms to Clinical Benefits.

  2024cites this paper
• TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates.

  2024cites this paper
• Therapeutic potential of CBD in Autism Spectrum Disorder.

  2024cites this paper
• Historical perspective on the therapeutic potential of cannabidiol.

  2024cites this paper
• New insights into the involvement of serotonin and BDNF-TrkB signalling in cannabidiol's antidepressant effect.

  2024cites this paper
• Direct Inhibition of BK Channels by Cannabidiol, One of the Principal Therapeutic Cannabinoids Derived from Cannabis sativa.

  2024cites this paper
• Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer’s Disease

  2024cites this paper
• Knockdown siRNA targeting GPR55 reveals significant differences between the anti-inflammatory actions of KLS-13019 and cannabidiol

  2024cites this paper
• Cannabidiol improves maternal obesity-induced behavioral, neuroinflammatory and neurochemical dysfunctions in the juvenile offspring.

  2024cites this paper
• Therapeutic potential of cannabidiol (CBD) in the treatment of cardiovascular diseases

  2024cites this paper
• Presynaptic antiseizure medications - basic mechanisms and clues for their rational combinations

  2024cites this paper
• Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders

  2024cites this paper
• Cannabidiol exhibits anxiolytic-like effects and antipsychotic-like effects in mice models.

  2024cites this paper
• Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis

  2024cites this paper
• Cannabidiol Intervention for Muscular Tension, Pain, and Sleep Bruxism Intensity—A Randomized, Double-Blind Clinical Trial

  2024cites this paper
• Tracing topics and trends in drug‐resistant epilepsy research using a natural language processing–based topic modeling approach

  2024cites this paper
• The latest advances in the pharmacological management of focal epilepsies in children: a narrative review

  2024cites this paper
• Cannabidiol modulates hippocampal genes involved in mitochondrial function, ribosome biogenesis, synapse organization, and chromatin modifications

  2024cites this paper
• The Effect of Cannabidiol on Subjective Responses to Endurance Exercise: A Randomised Controlled Trial

  2024cites this paper
• The longitudinal effects of cannabidiol on brain temperature in patients with treatment-resistant epilepsy.

  2024cites this paper